Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 050818

TOBRADEX ST (DEXAMETHASONE; TOBRAMYCIN)
0.05%;0.3% Marketing Status: Prescription

Active Ingredient: DEXAMETHASONE; TOBRAMYCIN
Proprietary Name: TOBRADEX ST
Dosage Form; Route of Administration: SUSPENSION/DROPS; OPHTHALMIC
Strength: 0.05%;0.3%
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N050818
Product Number: 001
Approval Date: Feb 13, 2009
Applicant Holder Full Name: NOVARTIS PHARMACEUTICALS CORP
Marketing Status:  Prescription
Patent and Exclusivity Information

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English